Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Clinical Study of Intravenous Immunoglobulin

ClinicalTrials.gov ID: NCT00468273

Public ClinicalTrials.gov record NCT00468273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 12:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Clinical Study of Immune Globulin Intravenous (Human) Omr-IgG-am IGIV in Subjects With Primary Immune Deficiency Diseases

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to measure the pharmacokinetics, efficacy and safety of Immune Globulin Intravenous (Human) \[IGIV\], 5% Solution Omr-IgG-am™ in patients with primary immunodeficiency diseases.

Study identification

NCT ID
NCT00468273
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
FFF Enterprises
Industry
Enrollment
57 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
May 2009 (Actual)
Completion
Aug 2009 (Actual)
Last update posted
Aug 11, 2014

2006 – 2009

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Mattel Children's Hospital of UCLA Los Angeles California 90095-1752 —
1st Allergy and Clinical Research Center Centennial Colorado 80112 —
Allergy Associates of the Palm Beaches North Palm Beach Florida 33408 —
Rush University Medical Center Chicago Illinois 60612 —
Rainbow Babies and Children's Hospital Cleveland Ohio 44106 —
Optimed Research, LLC Columbus Ohio 43235 —
Pediatric Allergy Immunology Associates Dallas Texas 75230 —
Allergy, Asthma and Immunology Clinic PA Irving Texas 75230 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00468273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2014 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00468273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →